Table 3 Parameters of organ function of the study groups during the 24-hour interventional period.
Variable | Group | Shock time | 4 h | 8 h | 16 h | 24 h |
---|---|---|---|---|---|---|
Lactate [mmol·L−1] | Control | 1.8 [1.8; 1.9] | 2.7 [2.4; 3.0] | 2.9 [2.5; 3.2] | 2.9 [2.7; 3.2] | 2.2 [1.8; 3.8] |
TP first-line | 1.9 [1.9; 2.0] | 3.3 [3.1; 3.5] | 3.6 [2.9; 3.9] | 3.3 [2.3; 3.5] | 2.6 [2.5; 3.2] | |
TP second-line | 1.8 [1.8; 2.2] | 2.6 [2.2; 2.9] | 2.6 [2.3; 3.5] | 2.8 [2.1; 4.7] | 3.3 [3.1; 3.6] | |
Creatinine [mmol·L−1] | Control | 1.5 [1.2; 1.7] | 1.1 [0.9; 1.2] | 1.2 [1; 1.4] | 1.1 [0.9; 1.7] | 1.3 [1.1; 2.3] |
TP first-line | 1.8 [1.3; 1.9] | 1.4 [1.1; 1.8] | 1.5 [1.1; 1.6] | 2.2 [0.9; 2.3] | 2.1 [1.2; 2.5] | |
TP second-line | 1.3 [1.2; 2.0] | 1.1 [0.8; 1.2] | 1.4 [0.8; 1.6] | 1.6 [1.3; 2.0] | 1.9 [1.6; 2.6] | |
Crea- Clearance [mL·min-1·m−2] | Control | 11 [4; 39] | 55 [34; 73] | 65 [43; 69] | 32 [10; 53] | 14 [9; 22] |
TP first-line | 0 [0; 8] | 60 [41; 83] | 41 [21, 68] | 55 [25; 55] | 4 [0; 36] | |
TP second-line | 3 [0; 9] | 61 [40; 96] | 50 [21; 70] | 16 [6; 36] | 0 [0; 18] | |
Diuresis [mL·kg−1·h−1] | Control | 0.1 [0.1; 0.4] | 0.9 [0.5; 1.6] | 0.5 [0.2; 1.0] | 0.6 [0.2; 1.2] | 0.6 [0.3; 0.9] |
TP first-line | 0 [0; 0.1] | 1.2 [0.7; 2.4] | 0.3 [0; 0.7] | 0.4 [0.4; 0.6] | 0.1 [0; 0.3] | |
TP second-line | 0.1 [0; 0.1] | 0.8 [0.7; 2.0] | 0.3 [0.2; 0.5] | 0.4 [0.3; 0.6] | 0.2 [0; 0.4] | |
Bilirubin [mg·dL−1] | Control | 0.1 [0.1; 0.8] | 0.1[0.1; 0.1] | 0.1 [0.1; 0.1] | 0.1 [0.1; 0.1] | 0.1 [0.1; 0.1] |
TP first-line | 0.1 [0.1; 0.1] | n.a. | 0.1 [0.1; 0.1] | 0.1 [0.1; 0.1] | 0.1 [0.1; 0.1] | |
TP second-line | 0.1 [0.1; 0.1] | 0.1 [0.1; 0.8] | 0.1 [0.1; 0.1] | 0.1 [0.1; 0.2] | 0.1 [0.1; 0.1] | |
Protein [g·dL−1] | Control | 4.1 [3.9; 4.5] | 1.9 [1.4; 2.3] | 1.5 [1.0; 1.9] | 1.1 [0.8; 1.7] | 1.4 [1.4; 1.5] |
TP first-line | 4.3 [4.1; 5.0] | 1.8 [1.5; 2.5] | 1.3 [1.1; 1.9] | 1.8 [1.0; 1.9] | 1.9 [1.3; 2.0] | |
TP second-line | 4.6 [4.1; 5.1] | 1.9 [1.5; 2.3] | 1.3 [1.1; 1.8] | 1.3 [1.2; 1.8] | 1.4 [1.3; 1.8] | |
Arginine vasopressin [pg·mL−1] | Control | 239 [195; 291] | 8 [5; 12] | 11 [3; 96] | 9 [4; 19] | 9 [8; 14] |
TP first-line | 104 [30; 163] | 5 [4; 10] | 8 [4; 28] | 15 [3; 20] | 10 [8; 15] | |
TP second-line | 257 [190; 273] | 6 [4; 24] | 12 [5; 20] | 16 [12; 25] | 25 [8; 40] |